Identification of HLA‐DRB1*1501‐restricted T‐cell epitopes from human prostatic acid phosphatase
Identifieur interne : 002C48 ( Main/Exploration ); précédent : 002C47; suivant : 002C49Identification of HLA‐DRB1*1501‐restricted T‐cell epitopes from human prostatic acid phosphatase
Auteurs : Elena N. Klyushnenkova [États-Unis] ; Diana V. Kouiavskaia [États-Unis] ; James A. Kodak [États-Unis] ; Arthur A. Vandenbark [États-Unis] ; Richard B. Alexander [États-Unis]Source :
- The Prostate [ 0270-4137 ] ; 2007-07-01.
Abstract
BACKGROUND: The crucial role of CD4 T‐cells in anti‐tumor immune response is widely recognized, yet the identification of HLA class II‐restricted epitopes derived from tumor antigens has lagged behind compared to class I epitopes. This is particularly true for prostate cancer. Based on the hypothesis that successful cancer immunotherapy will likely resemble autoimmunity, we searched for the CD4 T‐cell epitopes derived from prostatic proteins that are restricted by human leukocyte antigen (HLA)‐DRB1*1501, an allele associated with granulomatous prostatitis (GP), a disease that may have an autoimmune etiology. One of the antigens implicated in the development of autoimmunity in the prostate is prostatic acid phosphatase (PAP), which is also considered a promising target for prostate cancer immunotherapy. METHODS: We immunized transgenic (tg) mice engineered to express HLA‐DRB1*1501 with human PAP. A library of overlapping 20‐mer peptides spanning the entire human PAP sequence was screened in vitro for T‐cell recognition by proliferative and interferon (IFN)‐γ enzyme‐linked immunosorbent spot (ELISPOT) assays. RESULTS: We identified two 20‐mer peptides, PAP (133–152), and PAP (173–192), that were immunogenic and naturally processed from whole PAP in HLA‐DRB1*1501 tg mice. These peptides were also capable of stimulating CD4 T lymphocytes from HLA‐DRB1*1501‐positive patients with GP and normal donors. CONCLUSIONS: These peptides can be used for the design of a new generation of peptide‐based vaccines against prostate cancer. The study can also be helpful in understanding the role of autoimmunity in the development of some forms of chronic prostatitis. Prostate 67: 1019–1028, 2007. © 2007 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/pros.20575
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B06
- to stream Istex, to step Curation: 001B06
- to stream Istex, to step Checkpoint: 000901
- to stream Main, to step Merge: 002C74
- to stream Main, to step Curation: 002C48
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of HLA‐DRB1*1501‐restricted T‐cell epitopes from human prostatic acid phosphatase</title><author><name sortKey="Klyushnenkova, Elena N" sort="Klyushnenkova, Elena N" uniqKey="Klyushnenkova E" first="Elena N." last="Klyushnenkova">Elena N. Klyushnenkova</name></author><author><name sortKey="Kouiavskaia, Diana V" sort="Kouiavskaia, Diana V" uniqKey="Kouiavskaia D" first="Diana V." last="Kouiavskaia">Diana V. Kouiavskaia</name></author><author><name sortKey="Kodak, James A" sort="Kodak, James A" uniqKey="Kodak J" first="James A." last="Kodak">James A. Kodak</name></author><author><name sortKey="Vandenbark, Arthur A" sort="Vandenbark, Arthur A" uniqKey="Vandenbark A" first="Arthur A." last="Vandenbark">Arthur A. Vandenbark</name></author><author><name sortKey="Alexander, Richard B" sort="Alexander, Richard B" uniqKey="Alexander R" first="Richard B." last="Alexander">Richard B. Alexander</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:58907371FB3DF76E502B7154DBD5BB13126E1297</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/pros.20575</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-5HZVGH2P-B/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001B06</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B06</idno><idno type="wicri:Area/Istex/Curation">001B06</idno><idno type="wicri:Area/Istex/Checkpoint">000901</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000901</idno><idno type="wicri:doubleKey">0270-4137:2007:Klyushnenkova E:identification:of:hla</idno><idno type="wicri:Area/Main/Merge">002C74</idno><idno type="wicri:Area/Main/Curation">002C48</idno><idno type="wicri:Area/Main/Exploration">002C48</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Identification of HLA‐DRB1*1501‐restricted T‐cell epitopes from human prostatic acid phosphatase</title><author><name sortKey="Klyushnenkova, Elena N" sort="Klyushnenkova, Elena N" uniqKey="Klyushnenkova E" first="Elena N." last="Klyushnenkova">Elena N. Klyushnenkova</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Division of Urology, University of Maryland School of Medicine, Baltimore</wicri:cityArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>VA Maryland Health Care System, Baltimore</wicri:cityArea></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Correspondence address: University of Maryland School of Medicine, Department of Surgery, 10 S. Pine Street, MSTF, Room 4‐00A, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Kouiavskaia, Diana V" sort="Kouiavskaia, Diana V" uniqKey="Kouiavskaia D" first="Diana V." last="Kouiavskaia">Diana V. Kouiavskaia</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Division of Urology, University of Maryland School of Medicine, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Kodak, James A" sort="Kodak, James A" uniqKey="Kodak J" first="James A." last="Kodak">James A. Kodak</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Division of Urology, University of Maryland School of Medicine, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Vandenbark, Arthur A" sort="Vandenbark, Arthur A" uniqKey="Vandenbark A" first="Arthur A." last="Vandenbark">Arthur A. Vandenbark</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Oregon</region></placeName><wicri:cityArea>Department of Neuroimmunology, Portland VA Medical Center, Portland Oregon and Departments of Neurology, and Molecular Microbiology & Immunology, Oregon Health & Science University, Portland</wicri:cityArea></affiliation></author><author><name sortKey="Alexander, Richard B" sort="Alexander, Richard B" uniqKey="Alexander R" first="Richard B." last="Alexander">Richard B. Alexander</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>Division of Urology, University of Maryland School of Medicine, Baltimore</wicri:cityArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>VA Maryland Health Care System, Baltimore</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">The Prostate</title><title level="j" type="alt">PROSTATE, THE</title><idno type="ISSN">0270-4137</idno><idno type="eISSN">1097-0045</idno><imprint><biblScope unit="vol">67</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1019">1019</biblScope><biblScope unit="page" to="1028">1028</biblScope><biblScope unit="page-count">10</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-07-01">2007-07-01</date></imprint><idno type="ISSN">0270-4137</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0270-4137</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BACKGROUND: The crucial role of CD4 T‐cells in anti‐tumor immune response is widely recognized, yet the identification of HLA class II‐restricted epitopes derived from tumor antigens has lagged behind compared to class I epitopes. This is particularly true for prostate cancer. Based on the hypothesis that successful cancer immunotherapy will likely resemble autoimmunity, we searched for the CD4 T‐cell epitopes derived from prostatic proteins that are restricted by human leukocyte antigen (HLA)‐DRB1*1501, an allele associated with granulomatous prostatitis (GP), a disease that may have an autoimmune etiology. One of the antigens implicated in the development of autoimmunity in the prostate is prostatic acid phosphatase (PAP), which is also considered a promising target for prostate cancer immunotherapy. METHODS: We immunized transgenic (tg) mice engineered to express HLA‐DRB1*1501 with human PAP. A library of overlapping 20‐mer peptides spanning the entire human PAP sequence was screened in vitro for T‐cell recognition by proliferative and interferon (IFN)‐γ enzyme‐linked immunosorbent spot (ELISPOT) assays. RESULTS: We identified two 20‐mer peptides, PAP (133–152), and PAP (173–192), that were immunogenic and naturally processed from whole PAP in HLA‐DRB1*1501 tg mice. These peptides were also capable of stimulating CD4 T lymphocytes from HLA‐DRB1*1501‐positive patients with GP and normal donors. CONCLUSIONS: These peptides can be used for the design of a new generation of peptide‐based vaccines against prostate cancer. The study can also be helpful in understanding the role of autoimmunity in the development of some forms of chronic prostatitis. Prostate 67: 1019–1028, 2007. © 2007 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li><li>Oregon</li></region></list><tree><country name="États-Unis"><region name="Maryland"><name sortKey="Klyushnenkova, Elena N" sort="Klyushnenkova, Elena N" uniqKey="Klyushnenkova E" first="Elena N." last="Klyushnenkova">Elena N. Klyushnenkova</name></region><name sortKey="Alexander, Richard B" sort="Alexander, Richard B" uniqKey="Alexander R" first="Richard B." last="Alexander">Richard B. Alexander</name><name sortKey="Alexander, Richard B" sort="Alexander, Richard B" uniqKey="Alexander R" first="Richard B." last="Alexander">Richard B. Alexander</name><name sortKey="Klyushnenkova, Elena N" sort="Klyushnenkova, Elena N" uniqKey="Klyushnenkova E" first="Elena N." last="Klyushnenkova">Elena N. Klyushnenkova</name><name sortKey="Klyushnenkova, Elena N" sort="Klyushnenkova, Elena N" uniqKey="Klyushnenkova E" first="Elena N." last="Klyushnenkova">Elena N. Klyushnenkova</name><name sortKey="Klyushnenkova, Elena N" sort="Klyushnenkova, Elena N" uniqKey="Klyushnenkova E" first="Elena N." last="Klyushnenkova">Elena N. Klyushnenkova</name><name sortKey="Kodak, James A" sort="Kodak, James A" uniqKey="Kodak J" first="James A." last="Kodak">James A. Kodak</name><name sortKey="Kouiavskaia, Diana V" sort="Kouiavskaia, Diana V" uniqKey="Kouiavskaia D" first="Diana V." last="Kouiavskaia">Diana V. Kouiavskaia</name><name sortKey="Vandenbark, Arthur A" sort="Vandenbark, Arthur A" uniqKey="Vandenbark A" first="Arthur A." last="Vandenbark">Arthur A. Vandenbark</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C48 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C48 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:58907371FB3DF76E502B7154DBD5BB13126E1297
|texte= Identification of HLA‐DRB1*1501‐restricted T‐cell epitopes from human prostatic acid phosphatase
}}
| This area was generated with Dilib version V0.6.33. |  |